A PROSPECTIVE, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, FORCED-TITRATION, MULTICENTRE, PARALLEL GROUP, ONE YEAR TREATMENT TRIAL TO COMPARE TELMISARTAN (MICARDIS) 80 MG VERSUS LOSARTAN (COZAAR) 100 MG, IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS WITH OVERT NEPHROPATHY (AMADEO STUDY):